Literature DB >> 27743773

Radiotherapy in Glioblastoma: the Past, the Present and the Future.

C Gzell1, M Back2, H Wheeler3, D Bailey4, M Foote5.   

Abstract

The aim of this review is to explore the changing utility of radiotherapy in the treatment of patients with glioblastoma over the past 60 years. Together with surgery, radiotherapy has always been the cornerstone of treatment of glioblastoma, but techniques have significantly advanced over this time. The exploration of early two-dimensional techniques, investigation of dose escalation, concomitant chemotherapy and modern techniques, including intensity-modulated radiotherapy, image-guided radiotherapy, and volumetric-modulated arc therapy will be covered. In addition, current controversies including decreasing margin size, re-irradiation, treatment of elderly patients, and novel imaging tracers will be discussed. Future directions including immunotherapy and tumour treating fields are examined. Radiotherapy-based treatments cannot rely solely on advances in chemotherapy or immunotherapy to improve the overall survival of patients with glioblastoma. Radiation oncology needs to continue to develop and improve the delivery, target definition, and dose of radiotherapy to these patients to improve their survival and the toxicity associated with treatment.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GBM; IMRT; TTF; VMAT; glioblastoma; radiotherapy

Mesh:

Year:  2016        PMID: 27743773     DOI: 10.1016/j.clon.2016.09.015

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  16 in total

Review 1.  Immunotherapy in CNS cancers: the role of immune cell trafficking.

Authors:  Nivedita M Ratnam; Mark R Gilbert; Amber J Giles
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

2.  Sodium butyrate induces senescence and inhibits the invasiveness of glioblastoma cells.

Authors:  Hidemitsu Nakagawa; Satoru Sasagawa; Kazuyuki Itoh
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

3.  Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study.

Authors:  Yung-Shin Sun
Journal:  Comput Math Methods Med       Date:  2018-02-22       Impact factor: 2.238

4.  Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.

Authors:  Fengyu Zhang; Ruilai Liu; Haishi Zhang; Cheng Liu; Chunfang Liu; Yuan Lu
Journal:  BMC Cancer       Date:  2020-07-18       Impact factor: 4.430

5.  Autophagic flux response and glioblastoma sensitivity to radiation.

Authors:  Achilleas G Mitrakas; Dimitra Kalamida; Alexandra Giatromanolaki; Stamatia Pouliliou; Avgi Tsolou; Rafail Kyranas; Michael I Koukourakis
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

Review 6.  Herpes Simplex Virus 1 encephalitis with normal cerebrospinal fluid after brain radiotherapy in a patient with glioblastoma. A case report and review of literature.

Authors:  Carlotta Mutti; Erica Curti; Rosario Ciliento; Andrea Melpignano; Irene Florindo; Lucia Zinno; Enrico Sasso; Liborio Parrino; Giovanni Pavesi; Anna Elisabetta Vaudano
Journal:  Acta Biomed       Date:  2019-05-23

7.  Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.

Authors:  Mehrdad Khoshnevis; Claude Carozzo; Richard Brown; Manuel Bardiès; Catherine Bonnefont-Rebeix; Sara Belluco; Christophe Nennig; Lionel Marcon; Olivier Tillement; Hélène Gehan; Cédric Louis; Ilyes Zahi; Thierry Buronfosse; Thierry Roger; Frédérique Ponce
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

8.  NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.

Authors:  Antonio Lucena-Cacace; Daniel Otero-Albiol; Manuel P Jiménez-García; Javier Peinado-Serrano; Amancio Carnero
Journal:  Oncotarget       Date:  2017-08-28

Review 9.  Advances in Radiotherapy for Glioblastoma.

Authors:  Justin Mann; Rohan Ramakrishna; Rajiv Magge; A Gabriella Wernicke
Journal:  Front Neurol       Date:  2018-01-15       Impact factor: 4.003

Review 10.  Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp's Trial: More Controversies than Standards?

Authors:  Tomas Kazda; Adam Dziacky; Petr Burkon; Petr Pospisil; Marek Slavik; Zdenek Rehak; Radim Jancalek; Pavel Slampa; Ondrej Slaby; Radek Lakomy
Journal:  Radiol Oncol       Date:  2018-06-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.